Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Case Report

Allopurinol-induced DRESS syndrome mimicking biliary obstruction

Hyung Gyu Choi, Junsu Byun, Chae Ho Moon, Jong Ho Yoon, Ki Young Yang, Su Cheol Park, Chul Ju Han

Clin Mol Hepatol. 2014;20(1):71-75. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.71

View: 10035 Download: 85 Web of Science: 6 Crossref: 7

4

A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis

Jae Young Yoon , Sun Yang Min , Ju Yee Park , Seung Goun Hong , Sang Jong Park , So Ya Paik , Young Min Park

Clin Mol Hepatol. 2008;14(1):97-101. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.97

View: 5878 Download: 75 Crossref: 8

A Case of Vanishing Bile Duct Syndrome Associated with Hypersensitivity to Allopurinol

Seong Ho Choi, M.D., Soo Hyun Yang, M.D., Young Bong Song, M.D., Hye Jin Kim, M.D., Yeoung Tae Seo, M.D., Dong Seog Choi, M.D., Kyoung Hyoub Moon, M.D., Jong Hoon Byun, M.D. and Eun Sil Yu, M.D.

Clin Mol Hepatol. 2005;11(1):80-85. Published online January 1, 1970

View: 2432 Download: 28

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5409	MAFLD: How is it different from NAFLD?
Viewed By 5220	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5098	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search